New oral cancer pill tested in advanced tumors
Disease control
Terminated
This early-stage study tested a new oral medication called ATX-559 in patients with advanced solid tumors that had stopped responding to standard treatments. The main goals were to find a safe dose and see how the drug behaves in the body. The trial was terminated after enrolling…
Phase: PHASE1 • Sponsor: Accent Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC